Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The natural human adaptive IgG-specific immune response is skewed towards non-protective tail domains of DNABII proteins.

Frontiers in immunology·2026

Same author

Characterization of a conserved outer-membrane protein in non-typeable <i>Haemophilus influenzae</i> with an unidentified impact on phenotype.

Microbiology spectrum·2026

Same author

Whose duty is it to advise that some healthcare professionals will not help you or refer you?

Journal of medical ethics·2026

Same author

In and Out of the Loop: Responsibility for Harms After Service Member Enhancement.

AJOB neuroscience·2026

Same author

Grounding Responsibility to Parties Who Suffer Harm Following Biomodifications to Enhance Military Function.

AJOB neuroscience·2026

Same author

Left Behind: The Clinical Implications of Excluding Students and Residents from Professional Obligations.

The American journal of bioethics : AJOB·2025

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Infections in chronic lung diseases.

G Iyer Parameswaran¹, Timothy F Murphy

¹Division of Infectious Diseases, Department of Medicine, 3495 Bailey Avenue, University at Buffalo, State University of New York, Buffalo, NY 14215, USA.

Infectious Disease Clinics of North America

|September 11, 2007

Summary

This review examines infections common in chronic lung diseases like COPD, bronchiectasis, and cystic fibrosis. It focuses on infections occurring in patients with these established conditions, not their initial causes.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Experiment Videos

Last Updated: Jul 11, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

Pulmonology
Infectious Diseases
Medical Research

Background:

Chronic lung diseases, including chronic obstructive pulmonary disease (COPD), bronchiectasis, and cystic fibrosis, are widespread globally.
These conditions lead to substantial mortality and patient suffering.
Infections are a significant complication in patients with these chronic respiratory conditions.

Purpose of the Study:

To review and summarize the common infections encountered in patients with established chronic lung diseases.
To differentiate between infections causing these diseases and those occurring as complications.
To provide an overview of infectious challenges in COPD, bronchiectasis, and cystic fibrosis.

Main Methods:

Literature review of existing research on infections in chronic lung diseases.
Focus on studies detailing infections in the context of pre-existing COPD, bronchiectasis, and cystic fibrosis.
Synthesis of information regarding common pathogens and clinical implications.

Main Results:

Infections are a frequent and serious issue for individuals with chronic lung diseases.
Specific pathogens and infection patterns vary across COPD, bronchiectasis, and cystic fibrosis.
Understanding these infections is crucial for effective patient management.

Conclusions:

Infections represent a major clinical challenge in managing chronic lung diseases.
Further research is needed to optimize the prevention and treatment of infections in these patient populations.
This review highlights the importance of addressing infectious complications in chronic respiratory disease care.